Global Point of Care (PoC) Molecular Diagnostics Market 2020-2030

Bonafide Trust 28-09-2020 183 Pages Figures : 86 Tables : 87
Region : Global Category : Lifescience Biotechnology

Request new version

Request for updated version of the report at the same price

Order Now

Report Description
Table of Contents
List of Figure Tables

Global PoC molecular diagnostics market will reach $5,665.3 million by 2030, growing by 13.5% annually over 2020-2030 driven by increase in adoption of personalized medicine and surge in usage of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic. Highlighted with 87 tables and 86 figures, this 183-page report “Global Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Kits & Assays • Analyzers & Instruments • Software & Services Based on Technology, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Polymerase Chain Reaction (PCR) • Real-Time PCR (rt-PCR) • Digital PCR (d-PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) Genetic Sequencing-based Technology Microarray-based Technology Other Technologies Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Infectious Disease • Respiratory Infections • Hospital Acquired Infections • Sexually Transmitted Infections Gastrointestinal Infections Oncology Hepatitis Prenatal/Neonatal Testing Other Applications Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Hospitals • Clinics & Diagnostic Centers • Research and Academic Institutes • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Technology, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global PoC molecular diagnostics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abacus Diagnostica Oy Abbott Laboratories Alere Inc. Biocartis Group NV Biomerieux SA Bio-Rad Laboratories Inc Danaher Corporation DiaSorin S.p.A DxNA LLC. F. Hoffmann-La Roche Ltd. Hologic, Inc. Luminex Corporation Meridian Bioscience Inc. Mesa Biotech Inc. QIAGEN N.V. QuantuMDx Group Ltd. Quidel Corporation Spartan Biosciences Inc. Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 9

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 16

1.2.6 Market Size/Share Estimation 17

1.2.7 Research Limitations 18

1.3 Executive Summary 19

2 Market Overview and Dynamics 22

2.1 Market Size and Forecast 22

2.1.1 Impact of COVID-19 on World Economy 23

2.1.2 Impact of COVID-19 on the Market 26

2.2 Major Growth Drivers 28

2.3 Market Restraints and Challenges 33

2.4 Emerging Opportunities and Market Trends 36

2.5 Porter’s Fiver Forces Analysis 40

3 Segmentation of Global Market by Product 45

3.1 Market Overview by Product 45

3.2 Kits & Assays 47

3.3 Analyzers & Instruments 48

3.4 Software & Services 49

4 Segmentation of Global Market by Technology 50

4.1 Market Overview by Technology 50

4.2 Polymerase Chain Reaction (PCR) 52

4.2.1 Real-Time PCR (rt-PCR) 53

4.2.2 Digital PCR (d-PCR) 54

4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) 55

4.4 Genetic Sequencing-based Technology 56

4.5 Microarray-based Technology 57

4.6 Other Technologies 58

5 Segmentation of Global Market by Application 59

5.1 Market Overview by Application 59

5.2 Infectious Disease 61

5.2.1 Respiratory Infections 63

5.2.2 Hospital Acquired Infections 64

5.2.3 Sexually Transmitted Infections 65

5.3 Gastrointestinal Infections 66

5.4 Oncology 67

5.5 Hepatitis 68

5.6 Prenatal/Neonatal Testing 69

5.7 Other Applications 70

6 Segmentation of Global Market by End User 71

6.1 Market Overview by End User 71

6.2 Hospitals 73

6.3 Clinics & Diagnostic Centers 74

6.4 Research and Academic Institutes 75

6.5 Other End Users 76

7 Segmentation of Global Market by Region 78

7.1 Geographic Market Overview 2019-2030 78

7.2 North America Market 2019-2030 by Country 84

7.2.1 Overview of North America Market 84

7.2.2 U.S. 88

7.2.3 Canada 92

7.2.4 Mexico 94

7.3 European Market 2019-2030 by Country 96

7.3.1 Overview of European Market 96

7.3.2 Germany 100

7.3.3 UK 102

7.3.4 France 104

7.3.5 Spain 106

7.3.6 Italy 108

7.3.7 Russia 110

7.3.8 Rest of European Market 112

7.4 Asia-Pacific Market 2019-2030 by Country 114

7.4.1 Overview of Asia-Pacific Market 114

7.4.2 Japan 118

7.4.3 China 121

7.4.4 Australia 124

7.4.5 India 126

7.4.6 South Korea 128

7.4.7 Rest of APAC Region 130

7.5 South America Market 2019-2030 by Country 132

7.5.1 Argentina 135

7.5.2 Brazil 137

7.5.3 Chile 139

7.5.4 Rest of South America Market 141

7.6 MEA Market 2019-2030 by Country 142

7.6.1 UAE 145

7.6.2 Saudi Arabia 147

7.6.3 South Africa 149

7.6.4 Other National Markets 151

8 Competitive Landscape 152

8.1 Overview of Key Vendors 152

8.2 New Product Launch, Partnership, Investment, and M&A 156

8.3 Company Profiles 157

Abacus Diagnostica Oy 157

Abbott Laboratories 159

Alere Inc. 160

Biocartis Group NV 161

Biomerieux SA 162

Bio-Rad Laboratories Inc 163

Danaher Corporation 164

DiaSorin S.p.A 165

DxNA LLC. 166

F. Hoffmann-La Roche Ltd. 167

Hologic, Inc. 168

Luminex Corporation 169

Meridian Bioscience Inc. 170

Mesa Biotech Inc. 171

QIAGEN N.V. 172

QuantuMDx Group Ltd. 173

Quidel Corporation 174

Spartan Biosciences Inc. 175

Thermo Fisher Scientific 176

9 Investing in Global Market: Risk Assessment and Management 177

9.1 Risk Evaluation of Global Market 177

9.2 Critical Success Factors (CSFs) 180

Related Reports and Products 183

Figure 1. Research Method Flow Chart 13
Figure 2. Breakdown of Primary Research 15
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 19
Figure 5. Global Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 22
Figure 6. Impact of COVID-19 on Business 26
Figure 7. Primary Drivers and Impact Factors of Global Point of Care (PoC) Molecular Diagnostics Market 28
Figure 8. World Number of Deaths by Cause in 2017 31
Figure 9. World Number of Deaths from Cancers in 2017 32
Figure 10. Primary Restraints and Impact Factors of Global Point of Care (PoC) Molecular Diagnostics Market 33
Figure 11. Investment Opportunity Analysis 37
Figure 12. Porter’s Fiver Forces Analysis of Global Point of Care (PoC) Molecular Diagnostics Market 40
Figure 13. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue 45
Figure 14. Global Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 46
Figure 15. Global Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn 47
Figure 16. Global Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn 48
Figure 17. Global Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn 49
Figure 18. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue 50
Figure 19. Global Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%) 51
Figure 20. Global Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 52
Figure 21. Global Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn 53
Figure 22. Global Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn 54
Figure 23. Global Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn 55
Figure 24. Global Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn 56
Figure 25. Global Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn 57
Figure 26. Global Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn 58
Figure 27. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue 59
Figure 28. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 60
Figure 29. Global Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn 61
Figure 30. Global Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn 63
Figure 31. Global Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn 64
Figure 32. Global Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn 65
Figure 33. Global Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn 66
Figure 34. Global Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn 67
Figure 35. Global Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn 68
Figure 36. Global Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn 69
Figure 37. Global Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn 70
Figure 38. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue 71
Figure 39. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 72
Figure 40. Global Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn 73
Figure 41. Global Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn 74
Figure 42. Global Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn 75
Figure 43. Global Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn 76
Figure 44. Global Market Snapshot by Region 78
Figure 45. Geographic Spread of Worldwide Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, % of Sales Revenue 79
Figure 46. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%) 80
Figure 47. Health Spending as a Share of GDP by Country, 2015 and 2030 82
Figure 48. North American Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 85
Figure 49. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 86
Figure 50. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 87
Figure 51. U.S. Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 89
Figure 52. Canada Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 92
Figure 53. Point of Care (PoC) Molecular Diagnostics Market in Mexico, 2015-2030, $ mn 94
Figure 54. European Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 97
Figure 55. Breakdown of European Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 98
Figure 56. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 99
Figure 57. Point of Care (PoC) Molecular Diagnostics Market in Germany, 2019-2030, $ mn 100
Figure 58. Point of Care (PoC) Molecular Diagnostics Market in UK, 2019-2030, $ mn 102
Figure 59. Point of Care (PoC) Molecular Diagnostics Market in France, 2019-2030, $ mn 104
Figure 60. Point of Care (PoC) Molecular Diagnostics Market in Spain, 2019-2030, $ mn 106
Figure 61. Point of Care (PoC) Molecular Diagnostics Market in Italy, 2019-2030, $ mn 108
Figure 62. Point of Care (PoC) Molecular Diagnostics Market in Russia, 2019-2030, $ mn 110
Figure 63. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe, 2019-2030, $ mn 112
Figure 64. Asia-Pacific Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 115
Figure 65. Breakdown of APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 115
Figure 66. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 117
Figure 67. Point of Care (PoC) Molecular Diagnostics Market in Japan, 2019-2030, $ mn 119
Figure 68. Point of Care (PoC) Molecular Diagnostics Market in China, 2019-2030, $ mn 122
Figure 69. Point of Care (PoC) Molecular Diagnostics Market in Australia, 2019-2030, $ mn 124
Figure 70. Point of Care (PoC) Molecular Diagnostics Market in India, 2019-2030, $ mn 126
Figure 71. Point of Care (PoC) Molecular Diagnostics Market in South Korea, 2019-2030, $ mn 128
Figure 72. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC, 2019-2030, $ mn 130
Figure 73. South America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 133
Figure 74. Breakdown of South America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 133
Figure 75. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 134
Figure 76. Point of Care (PoC) Molecular Diagnostics Market in Argentina, 2019-2030, $ mn 135
Figure 77. Point of Care (PoC) Molecular Diagnostics Market in Brazil, 2019-2030, $ mn 137
Figure 78. Point of Care (PoC) Molecular Diagnostics Market in Chile, 2019-2030, $ mn 139
Figure 79. Point of Care (PoC) Molecular Diagnostics Market in Rest of South America, 2019-2030, $ mn 141
Figure 80. Point of Care (PoC) Molecular Diagnostics Market in Middle East and Africa (MEA), 2019-2030, $ mn 143
Figure 81. Breakdown of MEA Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 143
Figure 82. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 144
Figure 83. Point of Care (PoC) Molecular Diagnostics Market in UAE, 2019-2030, $ mn 145
Figure 84. Point of Care (PoC) Molecular Diagnostics Market in Saudi Arabia, 2019-2030, $ mn 147
Figure 85. Point of Care (PoC) Molecular Diagnostics Market in South Africa, 2019-2030, $ mn 149
Figure 86. Growth Stage of Global Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period 152

Table 1. Snapshot of Global Point of Care (PoC) Molecular Diagnostics Market, 2019-2030 20
Table 2. Growth Rate of World Real GDP, 2017-2021 24
Table 3. Main Product Trends and Market Opportunities in Global Point of Care (PoC) Molecular Diagnostics Market 36
Table 4. Global Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 45
Table 5. Global Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 50
Table 6. Global Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn 52
Table 7. Global Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 59
Table 8. Global Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn 62
Table 9. Global Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn 71
Table 10. Global Point of Care (PoC) Molecular Diagnostics Market by Region, 2019-2030, $ mn 79
Table 11. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 81
Table 12. Leading National Point of Care (PoC) Molecular Diagnostics Market, 2019 and 2030, $ mn 83
Table 13. North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 86
Table 14. U.S. Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 90
Table 15. U.S. Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 90
Table 16. U.S. Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 90
Table 17. Canada Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 93
Table 18. Canada Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 93
Table 19. Canada Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 93
Table 20. Mexico Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 95
Table 21. Mexico Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 95
Table 22. Mexico Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 95
Table 23. Europe Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 99
Table 24. Germany Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 101
Table 25. Germany Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 101
Table 26. Germany Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 101
Table 27. UK Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 103
Table 28. UK Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 103
Table 29. UK Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 103
Table 30. France Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 105
Table 31. France Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 105
Table 32. France Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 105
Table 33. Spain Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 107
Table 34. Spain Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 107
Table 35. Spain Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 107
Table 36. Italy Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 109
Table 37. Italy Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 109
Table 38. Italy Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 109
Table 39. Russia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 111
Table 40. Russia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 111
Table 41. Russia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 111
Table 42. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe by Country, 2019-2030, $ mn 113
Table 43. APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 116
Table 44. Japan Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 120
Table 45. Japan Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 120
Table 46. Japan Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 120
Table 47. China Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 123
Table 48. China Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 123
Table 49. China Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 123
Table 50. Australia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 125
Table 51. Australia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 125
Table 52. Australia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 125
Table 53. India Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 127
Table 54. India Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 127
Table 55. India Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 127
Table 56. South Korea Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 129
Table 57. South Korea Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 129
Table 58. South Korea Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 129
Table 59. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC by Country, 2019-2030, $ mn 131
Table 60. South America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 134
Table 61. Argentina Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 136
Table 62. Argentina Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 136
Table 63. Argentina Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 136
Table 64. Brazil Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 138
Table 65. Brazil Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 138
Table 66. Brazil Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 138
Table 67. Chile Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 140
Table 68. Chile Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 140
Table 69. Chile Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 140
Table 70. MEA Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 144
Table 71. UAE Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 146
Table 72. UAE Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 146
Table 73. UAE Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 146
Table 74. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 148
Table 75. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 148
Table 76. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 148
Table 77. South Africa Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 150
Table 78. South Africa Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 150
Table 79. South Africa Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 150
Table 80. Breakdown of Global Market by Key Vendor, 2019, % 154
Table 81. Abacus Diagnostica Oy: Company Snapshot 157
Table 82. Abacus Diagnostica Oy: Business Segmentation 157
Table 83. Abacus Diagnostica Oy: Product Portfolio 158
Table 84. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn 158
Table 85. Abacus Diagnostica Oy: Recent Developments 158
Table 86. Risk Evaluation for Investing in Global Market, 2019-2030 178
Table 87. Critical Success Factors and Key Takeaways 181

Interested in this report?
Get your FREE sample!

Safe and Secure SSl Encryption

Licensing options

3400
USD

Single User License
Site License
Global User License

How client has rates us?

Requirement Gathering & Methodology

Data Collection Techniques

Our Research Team & Data Sourcing

Data Science & Analytical Tools

Data Visualization & Presentation Skills

Project/ Report Delivery & After Sales Services

Testimonial

READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.

PRODUCT DEVELOPMENT MANAGER

CEO

Vivek Arora

BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!

EXECUTIVE DIRECTOR

Rahul Roy

THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.

SALES DIRECTOR

Arjun Prasad

THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH

MARKETING MANAGER

President

Manish Verma

Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

MARKETING DIRECTOR

Gautam Saxena

The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.

PRODUCT MANAGER

Tom Stone

I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.

Associate Director

Mark Wood

Global Point of Care (PoC) Molecular Diagnostics Market 2020-2030

Global Point of Care (PoC) Molecular Diagnostics Market 2020-2030